Fewer Cancer Visits; More Breast Cancer, Younger Women; Diet and Prostate Cancer - MedPage Today

Patient visits for cancer care have decreased significantly since the onset of the COVID-19 pandemic, according to one of the first systematic studies supporting anecdotal reports. (Jefferson Health, JCO Clinical Cancer Informatics)

One-fourth of patients with previously treated high-risk myelodysplastic syndromes responded to selinexor (Xpovio), and another 52% had stable disease. (The Lancet Haematology)

AstraZeneca and Daiichi Sankyo entered into a second multibillion dollar oncology agreement in as many years, this time to develop an antibody-drug conjugate cancer therapy targeting TROP-2. (Reuters)

A television news reporter learned she had thyroid cancer after a viewer wrote her about a suspicious lump on the reporter's neck. (CNN)

GlaxoSmithKline and genetic-testing company 23andMe launched a cancer clinical study, the first of multiple planned early-stage trials to use genetic information to develop new drugs. (Bloomberg)

Two lung cancer organizations announced a grant program to support studies of patients with lung cancer and COVID-19. (Lung Ambition Alliance, International Lung Cancer Foundation)

A study of global trends in breast cancer rates revealed a concerning increase among younger women living in higher-income nations. (University of Calgary, The Lancet Global Health)

A urine test for adrenal cancer could have a major impact on early diagnosis. (University of Birmingham, The Lancet Diabetes & Endocrinology)

An artificial intelligence system achieved near-perfect accuracy for identifying cancer in prostate biopsy specimens. (University of Pittsburgh Medical Center, The Lancet Digital Health)

More evidence that a "healthy diet" can reduce the risk of prostate cancer. (National Institute of Scientific Research [Canada], Nutrients)

Promising early results with a therapeutic vaccine to make HER2-positive breast cancer more responsive to immunotherapy. (Duke Health, Clinical Cancer Research)

  • author['full_name']

    Charles Bankhead is senior editor for oncology and also covers urology, dermatology, and ophthalmology. He joined MedPage Today in 2007. Follow



Comments

Popular posts from this blog

Sentinel lymph node biopsy: What cancer patients should know

Q&A

What Type of Cancer Causes Low Hemoglobin (Anemia)?